CCO (Chief Commercial Officer)
Mr Cohen joins Emergex from Janssen-Cilag, a subsidiary of Johnson & Johnson, where, since 2017, he was working as part of the EMEA regional Business Development Team and also responsible for Business Development in the UK pharmaceutical business.
He focussed on creating partnerships and strategic alliances to bring new assets into the organisation and enhance the capabilities of existing franchises. Prior to this role, Mr Cohen was the Commercial Lead for Infectious Diseases where he was responsible for the launch of a number of new therapeutic treatments in the fields of Hepatitis C and HIV. Prior to this, he was successful in a number of senior leadership roles in both Sales and Marketing fields across multiple therapy areas.